Rehovot, Israel

Rita Keynan

USPTO Granted Patents = 32 

 

 

Average Co-Inventor Count = 5.8

ph-index = 17

Forward Citations = 1,121(Granted Patents)


Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
Loading Chart...
32 patents (USPTO):Explore Patents

Title: Innovations in Medicine: The Impact of Rita Keynan

Introduction

Rita Keynan, an esteemed inventor based in Rehovot, Israel, has made significant contributions to the field of pharmaceuticals, particularly through her innovative formulations and compositions. With a remarkable portfolio of 32 patents, Rita is at the forefront of developing new methods and solutions in medicine that enhance therapeutic effectiveness.

Latest Patents

Rita Keynan's latest patents include revolutionary compositions designed to improve drug delivery and stability. One notable patent is for a topical tetracycline composition, which features a hydrophobic breakable composition that effectively delivers the antibiotic while maintaining its chemical stability for at least six months. This composition offers enhanced viscosity compared to traditional carriers, ensuring a better application experience for users.

Another of her significant patents relates to oil foamable carriers and formulations. This innovative waterless foamable pharmaceutical composition is designed for external application and includes various ingredients that enhance its effectiveness. The use of liquefied or compressed gas propellants, combined with stabilizing agents and liquid oils, allows for a versatile and efficient means of delivering active pharmaceutical ingredients.

Career Highlights

Throughout her career, Rita Keynan has worked with prominent companies like Foamix Pharmaceuticals Ltd. and Foamix Ltd., where her contributions have been instrumental in advancing the company's capabilities in the pharmaceutical sector. Her dedication to research and innovation has positioned her as a key figure in the development of effective therapeutic agents.

Collaborations

Rita has collaborated with notable professionals in her field, including Dov Tamarkin and David Schuz. These collaborations have fostered an environment of innovation and knowledge exchange, further enriching Rita's contributions to pharmaceutical science.

Conclusion

Rita Keynan's extensive patent portfolio and collaborations underscore her significant role in the development of advanced pharmaceutical compositions. Her work in creating stable and effective drug delivery systems continues to transform the landscape of medicine, highlighting the importance of innovation in healthcare. Through her dedication and ingenuity, Rita remains a vital contributor to the field, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…